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1. Introduction
  Diabetes is a metabolic disorder characterized by 
deficiency in production of insulin by pancreas, or by 
ineffectiveness of the produced insulin[1]. Synthetic 
antidiabetic agents may induce serious side effects thus are 
not suitable for use during pregnancy. In view of the adverse 
effects associated with the synthetic drugs, conventional 
antidiabetic plants exploration has aroused wide interest 
among researchers[2]. There are more then 1 200 plants 
species worldwide that are used in the treatment of diabetes 
mellitus and a substantial number of plants have shown 
effective hypoglycemic activity after laboratory testing[3]. 
Furthermore, after the recommendation made by WHO on 
diabetes mellitus, investigations on hypoglycemic agents 
from medicinal plants have become more important [4]. Also, 
diabetes has been treated orally with several medicinal 
plants or their extracts based on folklore medicine since 
ancient times. 
  Cassia siamea Lam. (Fabaceae) (C. siamea) is commonly 
known as ‘iron wood tree.’ The leaves of the plant are 
used as purgative and roots are employed for preventing 
convulsions in children[5]. Flowers of C. siamea have 
antioxidant activity[6]. The stem bark has analgesic, anti-
inflammatory and antiplasmodial effects[7,8]. Many tribal 
people have been using C. siamea leaves in diabetes 
problems. Furthermore, the plants from same genus Cassia 
kleinii, Cassia auriculata and Cassia glauca have been 
reported for antidiabetic activity[9-11]. 
  There is no previous report available on antidiabetic use 
of the plant. Hence, we report detail studies on antidiabetic 
and anti-lipidemic of the methanolic extract from leaves of 
C. siamea methanolic leaves extract (CSMLE), with a view to 
provide scientific evidence of modern lines.
2. Materials and methods
2.1. Plant material 
  C. siamea leaves were collected from the campus of 
Kurukshetra University, Kurukshetra, India and were 
identified by Dr. B.D. Vashishta, Department of Botany, 
Kurukshetra University, Kurukshetra, India. A voucher 
specimen of the plant is preserved in the herbarium of 
the Faculty of Pharmaceutical Sciences, Kurukshetra 
University (No. IPS/KUK/CS/2009). 
2.2. Extraction
  The leaves were dried under shade and powdered to 
coarse particles. The powdered material was defatted with 
petroleum ether (60-80 曟) in a Soxhlet extraction apparatus 
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and further extraction with methanol was made. The extract 
was dried at 45 曟 in rotary evaporator to produce a semisolid 
mass and stored in airtight containers in refrigerator below 
10 曟. 
2.3. Chemicals
  Streptozotocin was purchased from Sigma-Aldrich, 
India. The streptozotocin solution was prepared by freshly 
dissolving in citrate buffer (0.01 M, pH 4.5). Total cholesterol, 
high density lipoprotein (HDL)-cholesterol and triglyceride 
(TC) standard kits were purchased from Erba diagnostics 
Mannheim Gambh, Germany. All reagents used in study 
were analytical grade.
2.4. Animals
  Wistar rat of either sex, weighing about 150-250 g were 
used in the study. Animals were maintained under standard 
environmental conditions i.e. ambient temperature of 
(22 依2) 曟 and at 45%-55% relative humidity for 12 h under 
dark and light cycle. They were  fed with a standard pellet 
rats diet obtained from Ashirwad Industries, Chandigarh, 
India and water was supplied ad libitum. All the studies 
were conducted in accordance with the Animal Ethical 
Committee of the University.    
2.5. Induction of diabetes
  Rats were made diabetic by a single dose of streptozotocin 
(60 mg/kg body weight i.p.). The blood glucose level was 
checked before and 72 h after streptozotocin injection 
to confirm the development of diabetes. The diabetic 
animals were stabilized for five days, on the 6th day (day 0) 
experiment was started. Only those animals which showed 
blood glucose levels >250 mg/dL were separated and used 
for the study.
2.6. Experimental design
  All the diabetic animals were randomly divided into five 
groups with six animals in each group. They were treated 
once a day for 21 days as follows:
  Group I (Normal healthy control): given only vehicle 
(Tween 80, 1% v/v), Group II served as diabetic control: 
received only vehicle, Group III diabetic rats: received 
CSMLE 250 mg/kg.b.w., Group IV diabetic rats: received 
CSMLE 500 mg/kg.b.w, Group V diabetic rats: received 
(Glibenclamide 10 mg/kg.b.w.).
  Blood glucose was measured with elegance glucometer 
(CT-X10, Convergent Technologies, Germany) at weekly 
intervals i.e. 0, 7, 14 and 21 day after daily administration of 
extract orally. 
2.7. Anti-lipemic activity 
  On day 21, blood was collected by retro-orbital puncture 
under mild ether anesthesia from rats. Total cholesterol 
and triglyceride were determined by the method of Rifai et 
al[12]. HDL-cholesterol was also evaluated in normal and 
streptozotocin induces diabetic rats by autoanalyser (Erba 
Chem 7, Mannheim, Germany) using Erba diagnostic kits by 
methods of Burstein et al[13].
2.8. Statistical analysis
  All the data were expressed as mean依SEM. Statistical 
analysis was carried using Student’s t-test to analyze the 
significance between the groups. A value of P<0.05 was 
considered to be significant.
3. Results
  Daily administration of the extract for three weeks led to 
a dose dependent fall in blood glucose levels. Maximum 
effect seems to reach after 14 days of treatment and remains 
constant in third week. On 21st day, blood glucose (FBG) level 
was significantly reduced (P<0.01) in the diabetic rats treated 
with CSMLE. The antidiabetic effect of CSMLE on the blood 
glucose levels in diabetic rats was shown in Table 1. 
  There was a significant decrease (P<0.01) in the body 
weight of the diabetic controls (group II) compared with the 
normal controls (group I). During the weekly of observation 
of the flower extract-treated diabetic rats at doses of 250 
mg/kg, there was significant weight gains on day 21 relative to day 
0 (P<0.05), for rats treated with 500 mg/kg extract, the body 
weight almost maintained as the same (Table 1). 
  In the present study the total cholesterol and triglycerides 
was reduced in by 21 days treatment with CSMLE.  HDL 
cholesterol level was significantly improved by treatment of 
CSMLE as compared to diabetic control group (Table 2). 
  The results of present study indicated that the methanolic 
leaves extract of C. siamea  possesses significant 
hypoglycemic activity. It also maintained the lipid levels 
and body weight of rats.
4. Discussion
  Streptozotocin is a nitrosurea compound produced by 
Streptomyces achromogenes, which specifically induces 
DNA strand breakage in 毬-cells causing diabetes mellitus. 
Therefore, streptozotocin  has been widely employed 
to induce diabetes in experimental animals[14]. In this 
study, intraperitoneal administration of streptozotocin (60 mg/
kg) effectively induced diabetes in normal rats. Diabetes 
is reflected by glycosuria, hyperglycaemia, polyphagia, 
polydipsia and body wDeight loss when compared with 
normal rats[15]. In diabetes the increased blood sugar levels 
might be due to either insulin resistance of the body cells 
or decreased secretion of insulin from beta cells manifest in 
the decreased serum insulin levels[16]. The reduction in the 
serum insulin levels in the streptozotocin treated rats might 
be attributed to the reduced secretion of the hormone which 
might be due to the damage of the beta cells of endocrine 
pancreas. The streptozotocin selectively destroys the 
pancreatic cells and induce hyperglycemia[17,18]. Significant 
reduction of blood glucose levels was observed in diabetic 
rats orally treated with C. siamea leaves 500 mg/kg (P<0.01).
  Diabetes affects both glucose and lipid metabolism[19]. In 
the post prandial state elevated serum insulin increases 
lipoprotein lipase activity in adipose tissue and promotes 
fuel storage as triglycerides in normal metabolism[20]. 
The insulin deficiency depletes the activity level of 
lipoprotein lipase, thus leading to deranged lipoprotein 
metabolism during diabetes[21]. The lipoprotein levels in 
the streptozotocin induced diabetic rats of the present study 
reveal a significant alter in lipoprotein metabolism. The 
serum total cholesterol content increased significantly in 
diabetic animals. The repeated administration of C. siamea 
extract for a period of 21 days resulted in a significant 
decrease in lipid parameter levels when compared to the 
diabetic control. 
  The levels of serum total cholesterol and tryglycerides were 
found to be significantly reduced in the plant extracts treated 
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diabetic animals. This might be due to the reduced hepatic 
triglyceride synthesis and or reduced The HDL increased 
significantly in the plant extract treated rats indicating 
a reversed atherogenic risk. It is not known whether 
the extract has a direct effect on lipids or the present 
hypolipidemia is achieved due to controlled hyperglycemia. 
It was also observed that there was also significant weight 
gain in CSMLE treated diabetic rats compared with untreated 
diabetic animals. Untill, the exact mechanism of action of 
reduction of blood glucose levels after administration (p.o.) 
of the extracts is not clear. The extracts should further be 
subjected to bioactivity guided drug discovery to isolate a 
lead compound responsible for this activity.
  The C. siamea leaf extract is useful in controlling the 
blood glucose level. It also improves the lipid metabolism 
and body weight of rats. This could be useful for prevention 
or early treatment of diabetic disorders. Further studies 
are required to isolate, identify and characterize the active 
principles.
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Table 1
Effect of C. siamea extracts on blood glucose levels(mg/dL) and body weights(g) in diabetic rat (Mean依SEM). 
Groups
Initial day Day  7 Day 14 Day 21
 Blood glucose 
level 
weight
 Blood glucose 
level
weight
 Blood glucose 
level
weight
 Blood glucose 
level
weight
I 115.27 依 4.50 215.20 依 2.30  113.34 依 3.80  222.43 依 4.20  112.70 依 5.20  225.41 依 3.60  113.82 依 2.40  228.47 依 3.20
II 258.41 依 2.30 225.23 依 3.40  294.47 依 5.50  219.42 依 3.80  348.70 依 5.30  211.35 依 2.70  402.00 依 3.40  208.25 依 4.30
III 280.21 依 2.30 233.22 依 2.10  269.40 依 1.40*  230.32 依 2.30*  195.22 依 2.50*  231.13 依 2.50*  165.42 依 2.20*  232.85 依 2.30*
IV 289.22 依 1.50 230.23 依 2.40  220.11 依 2.30*  228.21 依 2.80  175.24 依 2.20**  229.32 依 2.20*  132.45 依 1.50**  229.92 依 2.50*
V 274.27 依 3.50 225.34 依 2.70  210.72 依 4.20**  227.34 依 2.30*  125.41 依 3.40*  228.78 依 2.30*  118.53 依 3.50**  231.25 依 1.80*
*P<0.05, **P<0.01, When groups III IV and V compared with diabetic control i.e. group II.
Table 2 
Effect of CSMLE on lipid profile (mg/dL). 
Groups Total cholesterol Triglycerides HDL cholesterol
I    87.28 依 3.80    82.42 依 5.16  37.32 依 2.90
II  254.73 依 7.60  150.52 依 4.71  28.23 依 2.20
III    123.32 依 2.40*   117.32 依 2.35*   33.24 依 2.20*
IV    110.12 依 1.40*     94.25 依 3.25*   38.23 依 1.50*
V       98.72 依 5.30**     83.47 依 4.50*     45.28 依 4.80**
Data represent means 依 SEM. *P<0.05, **P<0.01,  When groups III  IV and V compared with diabetic control i.e. group II.
